Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

GenMark Diagnostics Inc (GNMK) USD0.0001

Sell:$23.98 Buy:$23.99 Change: $0.005 (0.02%)
NASDAQ:0.10%
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

GenMark Diagnostics Inc USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 1 Apr 2021)

What is happening?

 

As you may be aware the Boards of GenMark Diagnostics Inc and Geronimo Acquisition Corp, a wholly owned subsidiary company of Roche Holding AG, recently announced the terms of a Takeover, in the way of a Tender Offer.  The Offer price is USD24.05 for each GenMark Diagnostics Inc Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Takeover Offer of USD24.05 for each GenMark Diagnostics Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

The Hargreaves Lansdown client deadline is noon on Thursday 15 April 2021.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$23.98
Buy:$23.99
Change: $0.005 (0.02%)
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

GenMark Diagnostics Inc USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 1 Apr 2021)

What is happening?

 

As you may be aware the Boards of GenMark Diagnostics Inc and Geronimo Acquisition Corp, a wholly owned subsidiary company of Roche Holding AG, recently announced the terms of a Takeover, in the way of a Tender Offer.  The Offer price is USD24.05 for each GenMark Diagnostics Inc Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Takeover Offer of USD24.05 for each GenMark Diagnostics Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

The Hargreaves Lansdown client deadline is noon on Thursday 15 April 2021.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$23.98
Buy:$23.99
Change: $0.005 (0.02%)
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

GenMark Diagnostics Inc USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 1 Apr 2021)

What is happening?

 

As you may be aware the Boards of GenMark Diagnostics Inc and Geronimo Acquisition Corp, a wholly owned subsidiary company of Roche Holding AG, recently announced the terms of a Takeover, in the way of a Tender Offer.  The Offer price is USD24.05 for each GenMark Diagnostics Inc Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Takeover Offer of USD24.05 for each GenMark Diagnostics Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

 

The Hargreaves Lansdown client deadline is noon on Thursday 15 April 2021.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown Clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

HL comment

HL comment is not available for this stock.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.